Your browser doesn't support javascript.
loading
Quantifying the bitter masking effect of drug-cyclodextrin complexation: NMR-ROESY mixing time approach.
Ueda, Tomohiko; Yamaguchi, Mei S; Christian-Tabak, Leela; Takai, Yoshiaki; Tode, Chisato.
Afiliação
  • Ueda T; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan. Electronic address: tomohiko.ueda@sumitomo-pharma.co.jp.
  • Yamaguchi MS; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.
  • Christian-Tabak L; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.
  • Takai Y; Sumitomo Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka, 554-0022, Japan.
  • Tode C; Kobe Pharmaceutical University, 4-19-1 Motoyama-kitamachi, Higashinada-ku, Kobe, Hyogo, 658-8558, Japan. Electronic address: c-tode@kobepharma-u.ac.jp.
Carbohydr Res ; 537: 109067, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38442683
ABSTRACT
Taste, especially unpleasant taste, can be key for patient compliance. In the formulation development process, drug-cyclodextrin (CD) inclusion complexes are often used to improve the solubility of a drug and/or mask its bitterness. This study aimed to evaluate the bitter masking effect of CDs on different drugs using NMR-ROESY analysis, human sensory tests, and e-tongue measurements. The strength of inclusion complex formation between drugs and CDs was investigated by NMR-ROSEY, and these results were compared to human sensory test results. In the sensory test, participants identified which drug-CD inclusion complexes were not bitter. NMR-ROSEY results aligned with the sensory tests; short magnetization transfer times corresponded to masked bitterness. The electrical tongue was not able to detect the taste of any of the drug-CD inclusion complexes. Additionally, we used NMR-ROSEY to determine which drug-CD inclusion complex formed in a system with multiple drug substances present. This research offers valuable insights into the bitter masking effect of CDs on different drugs and presents a comprehensive evaluation approach using various methods. This knowledge has significant implications for the pharmaceutical industry, clinical practice, and patient care, contributing to improved patient compliance and satisfaction with bitter medications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclodextrinas / Beta-Ciclodextrinas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclodextrinas / Beta-Ciclodextrinas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article